No Spike in Overdose Deaths From Relaxed Buprenorphine Regs

Measures enacted in the early days of the COVID-19 pandemic to increase access to buprenorphine did not lead to an increase in the proportion of overdose deaths involving the drug, new research suggests. Researchers say the data add weight to the argument for permanently adopting the pandemic-era prescribing regulations for buprenorphine, a treatment for opioid … Read more

SUD History Tied to Increased Risk of Death From Other Illnesses

Patients hospitalized for substance use disorder (SUD) are significantly more likely to die from other medical conditions later in life, a new study suggests. Researchers looked at mortality following a diagnosis of 28 different medical conditions, including heart failure, cancer, diabetes, multiple sclerosis, and stroke, and found patients with a history of alcohol or drug … Read more

Taking Prescribed Opioids Tied to Low Rates of Illicit Drug Use

Less than 5% of people whose opioid therapy is managed in a pain management setting test positive for illicit drugs, a new study found. An analysis of urine drug tests (UDTs) from 600,000 pain clinic patients also shows that those who test positive for their prescribed opioids are significantly less likely to test positive for … Read more

FDA, DEA Pushed to Make Gabapentin a Controlled Substance

In a bid to stop abuse and diversion of the anticonvulsant gabapentin, a watchdog group is petitioning federal regulators to make the drug a controlled substance. The nonprofit group Public Citizen has filed a petition with the US Food and Drug Administration (FDA) and the Drug Enforcement Administration (DEA), arguing that medication’s risks additional safeguards. … Read more